Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transitional Carcinoma of Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02951325
What this trial is testing

Bladder Cancer Adjuvant Radiotherapy Trial

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Tata Memorial Centre 153
Not applicableUnknownNCT04588168
What this trial is testing

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT01878188
What this trial is testing

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

Who this might be right for
Transitional Cell Carcinoma of Bladder
Anchiano Therapeutics Israel Ltd. 38
Very early researchNot Yet RecruitingNCT07272603
What this trial is testing

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Qilu Hospital of Shandong University 5
Early research (Phase 1)Study completedNCT00694798
What this trial is testing

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Cancer
Cadila Pharnmaceuticals 22
Testing effectiveness (Phase 2)WithdrawnNCT06424717
What this trial is testing

Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)

Who this might be right for
Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc.
Not applicableWithdrawnNCT01060319
What this trial is testing

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Who this might be right for
Bladder CancerSkin CancersBladder (Urothelial, Transitional Cell) Cancer+1 more
Stanford University
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Not applicableLooking for participantsNCT05646485
What this trial is testing

Bladder Cancer Screening Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaHematuria+1 more
University of Texas Southwestern Medical Center 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04579133
What this trial is testing

Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

Who this might be right for
Bladder CancerUrothelial Carcinoma
Latin American Cooperative Oncology Group 140
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Testing effectiveness (Phase 2)Study completedNCT04602078
What this trial is testing

Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
Spanish Oncology Genito-Urinary Group 82
Not applicableActive Not RecruitingNCT05520099
What this trial is testing

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

Who this might be right for
ImmunotherapyCancerBladder Cancer+16 more
Elephas 416
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05137262
What this trial is testing

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial CarcinomaBladder Cancer
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT01196403
What this trial is testing

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Wales Cancer Trials Unit 92
Testing effectiveness (Phase 2)Study completedNCT01620970
What this trial is testing

PF-03446962 in Relapsed or Refractory Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of Bladder
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Next Page